Ocular Immunology and Uveitis Foundation
Patient Information Medical Professionals Services
Patient Photo

What is Pars Planitis?

Medical Literature

PP Discussion Board

Uveitis Glossary

Kids and Parents

List of Specialists

Uveitis Awareness

Ask Dr. Foster

Uveitis Support Group

Low Vision
Instructions

 

Low Vision | Discussion Board | Foundation | Contact Us

Home | Patient Information | Treatment

Autoimmune Uveitis and It's Treatment

This section is designed to help you search the medical literature using the resources of the National Library of Medicine.  Use the links below, or create your own searches by going to www.PubMed.gov. 

Pars planitis is a treatable condition that may require the use of systemic immunosuppression medication and/or surgery to halt it's progression. Untreated, 20% of patients with pars planitis will have significant vision loss, and some will become blind.  The treatment algorithm for pars planitis may be found at this link.

A new paradigm for treating autoimmune-mediated ocular inflammation has been pioneered by C. Stephen Foster, M.D. at Harvard Medical School and the Ocular Immunology and Uveitis Foundation.  This treatment paradigm is based on a limited tolerance to corticosteroid use and a more proactive approach to corticosteroid-sparing immunomodulatory therapy in an effort to induce a durable remission of ocular inflammatory disease off all corticosteroids.

 

Getting Oriented:
Articles from the Ocular Immunology and Uveitis Foundation

Review Articles:

General Pub Med Searches

Immunomodulatory Therapy for Treatment of Autoimmune Uveitis

Research Updates

Publications by staff of the Ocular Immunology and Uveitis Foundation

 

 

Website updated: 08/19/2008
Copyright © 2002-2008 C. Stephen Foster M.D. All Rights Reserved.
 Disclaimer & Privacy Statement  | Children's Privacy Notice